| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851043 | American Journal of Kidney Diseases | 2008 | 8 Pages |
Abstract
Twice-weekly oral calcitriol has a modest antiproteinuric effect in patients with IgA nephropathy and persistent proteinuria despite angiotensin-converting enzyme-inhibitor or angiotensin receptor blocker therapy. Additional studies are needed to confirm the renal protecting effect of calcitriol in patients with chronic proteinuric kidney diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Cheuk-Chun MD, FRCP(Edin), Kai-Ming MBChB, MRCP(UK), Bonnie Ching-Ha MBBS, MRCP(UK), Kwok-Yi MBChB, MRCP(UK), Chi-Bon MBChB, FRCP(Edin), Philip Kam-Tao MD, FRCP,